Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.

[1]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[2]  P. L. Hildebrand,et al.  Preferred practice patterns. , 1996, Ophthalmology.

[3]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[4]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy-Reply , 1995 .

[5]  R. Worth,et al.  Mersey has changed its policy , 1995, BMJ.

[6]  S. Fava,et al.  Risk of intraocular haemorrhage remains unknown , 1995, BMJ.

[7]  D. Flanagan,et al.  Thrombolysis in patients with diabetes , 1995, BMJ.

[8]  K. Moriarty.  Prophylaxis with aspirin should be considered , 1995, BMJ.

[9]  J. Yudkin,et al.  Thrombolysis in patients with diabetes , 1995, BMJ.

[10]  E. Chew,et al.  Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. , 1995, Archives of ophthalmology.

[11]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[12]  M. Gammage,et al.  Acute Myocardial Infarction in Diabetic Patients in the Thrombolytic Era , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Fibrinolytictherapytrialistsf.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[14]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[15]  H. White,et al.  Significance of diabetes mellitus in patients with acute myocardial infraction receiving thrombolytic theraphy , 1993 .

[16]  H. White,et al.  Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. , 1993, Journal of the American College of Cardiology.

[17]  R. Califf,et al.  Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1993, Journal of the American College of Cardiology.

[18]  C. Simpfendorfer.  Efficacy of beta blockade, thrombolytic therapy, and coronary angioplasty in diabetic patients with coronary artery disease. , 1993, Cleveland Clinic journal of medicine.

[19]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[20]  P. Sunderraj.  Intraocular hemorrhage associated with intravenously administered streptokinase. , 1991, American journal of ophthalmology.

[21]  E. J. Brown,et al.  Selection Bias in the Use of Thrombolytic Therapy in Acute Myocardial Infarction , 1991 .

[22]  E. J. Brown,et al.  Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. , 1991, JAMA.

[23]  F. Pileggi,et al.  Retinal haemorrhage after thrombolytic therapy , 1991, The Lancet.

[24]  H. Hod,et al.  Thrombolytic therapy for acute myocardial infarction following recent cataract surgery. , 1991, American heart journal.

[25]  F. Klocke,et al.  Guidelines for the early management of patients with acute myocardial infarction , 1990 .

[26]  F. Klocke,et al.  ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag , 1990, Circulation.

[27]  I. Avni,et al.  Total hyphema following streptokinase administration eight days after cataract extraction. , 1990, The British journal of ophthalmology.

[28]  R. Califf,et al.  Thrombolysis and angioplasty in acute myocardial infarction. , 1988, The New England journal of medicine.

[29]  R. Klein,et al.  Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. , 1985, Ophthalmology.

[30]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons. , 1985, Advances in experimental medicine and biology.

[31]  R. Klein,et al.  Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. , 1985, Ophthalmology.

[32]  M. Vranic,et al.  Comparison of Type I and Type II Diabetes , 1985, Advances in Experimental Medicine and Biology.

[33]  J A Hanley,et al.  If nothing goes wrong, is everything all right? Interpreting zero numerators. , 1983, JAMA.

[34]  A L Siam,et al.  Proliferative diabetic retinopathy. , 2020, Bulletin of the Ophthalmological Society of Egypt.